Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

New-onset diabetes after renal transplantation: comparing ciclosporin and tacrolimus

Nature Clinical Practice Nephrology volume 4, pages 20–21 (2008)Cite this article

boxed-textVincenti F et al. (2007) Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7: 1506–1514

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Kasiske BL et al. (2003) Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3: 178–185

    Article  PubMed  Google Scholar 

  2. Davidson J et al. (2003) New-onset diabetes after transplantation: 2003 international consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 75 (Suppl): SS3–SS24

    PubMed  Google Scholar 

  3. Sharif A et al. (2006) The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: an underdiagnosed phenomenon. Transplantation 82: 1667–1672

    Article  PubMed  Google Scholar 

  4. Webster AC et al. (2005) Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ 331: 810–814

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Redmon JB et al. (1996) Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells. J Clin Invest 98: 2786–2793

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. University Hospital of Wales, Transplant Unit, Heath Park, Cardiff CF14 4XW, UK richard.moore@cardiffandvale.wales.nhs.uk

Authors and Affiliations

  1. R Moore is a Consultant Nephrologist and Clinical Director of Nephrology and Transplantation at the University Hospital of Wales, Cardiff, UK.,

    Richard Moore

Authors
  1. Richard Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author has received grant/research support from Astellas, Novartis, Roche and Wyeth, speaking honoraria from Novartis and Wyeth, and has acted as a consultant for Astellas, Novartis and Wyeth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moore, R. New-onset diabetes after renal transplantation: comparing ciclosporin and tacrolimus. Nat Rev Nephrol 4, 20–21 (2008). https://doi.org/10.1038/ncpneph0640

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0640

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing